GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.0795
-0.0030 (-3.64%)
Jun 23, 2026, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €18.64 million as of June 23, 2026. Its market cap has decreased by -32.08% in one year.
Market Cap
18.64M
Enterprise Value
29.09M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 18.64M, a decrease of -92.61%. That is a compound annual growth rate of -23.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 18.64M | -19.02% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MaaT Pharma | 52.01M |
| Fermentalg | 46.01M |
| THX Pharma Société Anonyme | 45.39M |
| Nicox | 33.23M |
| genOway Société anonyme | 22.13M |
| Advicenne | 15.68M |
| Aelis Farma | 13.19M |
| Poxel | 11.01M |